Sage Investment Advisers’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.28M Buy
5,046
+8
+0.2% +$1.86K 0.86% 31
2026
Q1
$1.23M Sell
5,038
-43
-0.8% -$10K 0.91% 32
2025
Q4
$1.05M Buy
+5,081
New +$1M 0.79% 37
2024
Q3
$828K Buy
5,108
+64
+1% +$10.2K 0.87% 35
2024
Q2
$737K Sell
5,044
-691
-12% -$103K 0.83% 34
2024
Q1
$907K Buy
5,735
+29
+0.5% +$4.62K 1.04% 31
2023
Q4
$894K Buy
5,706
+302
+6% +$46.3K 1.08% 31
2023
Q3
$842K Sell
5,404
-200
-4% -$33K 1.15% 30
2023
Q2
$928K Buy
5,604
+51
+0.9% +$8.23K 1.24% 30
2023
Q1
$861K Buy
5,553
+2
+0% +$323 1.15% 32
2022
Q4
$981K Buy
5,551
+1
+0% +$173 1.4% 28
2022
Q3
$907K Buy
5,550
+26
+0.5% +$4.4K 1.43% 27
2022
Q2
$981K Sell
5,524
-24
-0.4% -$4.28K 1.54% 25
2022
Q1
$983K Buy
5,548
+126
+2% +$21.4K 1.3% 27
2021
Q4
$927K Buy
+5,422
New +$888K 1.19% 28

Other funds holding JNJ

Sage Investment Advisers's JNJ Position: Q2 2026 in Review

Sage Investment Advisers increased its Johnson & Johnson (JNJ) stake by 0.16% in Q2 2026, buying an estimated $1.86K and bringing the position to 5,046 shares worth $1.28M. The position accounts for 0.86% of the portfolio, ranked #31.

Sage Investment Advisers first reported a position in JNJ in Q4 2021 and has held it in 15 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Sage Investment Advisers held 5,046 shares of Johnson & Johnson worth $1.28M as of Q2 2026.
  • Sage Investment Advisers bought 8 Johnson & Johnson shares in Q2 2026, an estimated $1.86K.
  • Johnson & Johnson made up 0.86% of Sage Investment Advisers's portfolio in Q2 2026, its #31 holding.
  • Sage Investment Advisers first reported a position in Johnson & Johnson in Q4 2021 and has held it in 15 quarters since.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Sage Investment Advisers's 13F filing for Q2 2026, filed 9 Jul 2026.